Targeting IL-17 and TH17 cells in chronic inflammation
The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Abstract
The key role of interleukin-17 (IL-17) and T helper 17 (T(H)17) cells in tissue inflammation, autoimmunity and host defence led to the experimental targeting of these molecules in mouse models of diseases as well as in clinical settings. Moreover, the demonstration that IL-17 and T(H)17 cells contribute to local and systemic aspects of disease pathogenesis, as well as the finding that the IL-17-T(H)17 cell pathway is regulated by IL-23, prompted the identification of inhibitors. These inhibitors include biotechnology products that target IL-23 as well as the leading member of the IL-17 family, IL-17A, and one of its receptors, IL-17 receptor A. Several clinical trials of these inhibitors are underway, and positive results have been obtained in psoriasis, rheumatoid arthritis and ankylosing spondylitis. This Review focuses on the current knowledge of the IL-17-T(H)17 cell pathway to better understand the positive as well as potential negative consequences of targeting them.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abs against IL-17/IL-17RA are in clinical trials for other autoimmune conditions [55].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [55]
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Research works printed but not linked: 1
- Baeten, D. et al. The anti-IL17A monoclonal antibody secukinumab (AIN457) showed good safety and efficacy in the treatment of active ankylosing spondylitis. Arthritis Rheum. 62, Abstract L3847 (2010).
Cited by
Items 601–700 of 1,000
Polyamines from myeloid-derived suppressor cells promote Th17 polarization and disease progression
Hu, C., Yu, Z., Ma, Z., Zhao, L., Wu, H., Shu, C., Pang, B., Yu, J., Xu, Y., Zhang, X., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.013 · Cited by 29
Celastrol regulates psoriatic inflammation and autophagy by targeting IL-17A
Park, A., & Heo, T.-H. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116256 · Cited by 29
LIU, X.-G., HOU, H.-W., & LIU, Y.-L. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3250 · Cited by 28
Wei, M., & Duan, D. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s91374 · Cited by 28
“Many human autoimmune diseases, including RA and psoriatic arthritis, are associated with abnormal Th17 activity.(16,17) Inhibition of IL-17 signaling through a ligand or its receptor could reduce inflammation and bone erosion in animal arthritis models.”
BackgroundLee, K.-H., Lee, C., Woo, J., Jeong, J., Jang, A.-H., & Yoo, C. (2018) · PubMed Central · doi:10.14348/molcells.2018.2123 · Cited by 30
“Fibroblasts, endothelial cells and epithelial cells are the major targets of IL-17A (Miossec and Kolls, 2012).”
BackgroundZhu, C., Boucheron, N., Al-Rubaye, O., Chung, B. K., Thorbjørnsen, L. W., Köcher, T., Schuster, M., Claudel, T., Halilbasic, E., Kunczer, V., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333297 · Cited by 28
Qu, Z., Li, H., Qiang, F., Liu, K., Wu, S., Li, J., & Zou, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156836 · Cited by 27
Discovery of N-indanyl benzamides as potent RORγt inverse agonists
Tian, J., Sun, N., Yu, M., Gu, X., Xie, Q., Shao, L., Liu, J., Liu, L., & Wang, Y. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.01.082 · Cited by 27
Xiao, C., Cheng, S., Li, R., Wang, Y., Zeng, D., Jiang, H., Liang, Y., Huang, R., Pan, H., Wu, X. Y., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.721273 · Cited by 25
“Th17 cells, a subtype of activated CD4 T cells, could promote the systemic inflammation of COPD through the secretion of IL17A (Miossec and Kolls, 2012; Ponce-Gallegos et al., 2017; Ni and Dong, 2018).”
BackgroundInfluentialIL-23 orchestrating immune cell activation in arthritis
Najm, A., & McInnes, I. B. (2021) · Rheumatology · doi:10.1093/rheumatology/keab266 · Cited by 25
Lin, Z., Huang, Q., Liu, J., Wang, H., Zhang, X., Zhu, Z., Zhang, W., Wei, Y., Liu, Z., & Du, W. (2022) · Aging · doi:10.18632/aging.204208 · Cited by 27
Complement Is Required for Microbe-Driven Induction of Th17 and Periodontitis
Wang, H., Ideguchi, H., Kajikawa, T., Mastellos, D. C., Lambris, J. D., & Hajishengallis, G. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2200338 · Cited by 25
CD4+ and CD8+ T cells reduce inflammation and promote bone healing in response to titanium implants
Avery, D., Morandini, L., Sheakley, L. S., Grabiec, M., & Olivares‐Navarrete, R. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.03.022 · Cited by 26
Conte, E., Iemmolo, M., Fagone, E., Gili, E., Fruciano, M., Genovese, T., Esposito, E., Cuzzocrea, S., & Vancheri, C. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.02.001 · Cited by 25
Negligible Immunogenicity of Induced Pluripotent Stem Cells Derived from Human Skin Fibroblasts
Lu, Q., Yu, M., Shen, C., Chen, X., Feng, T., Yao, Y., Li, J., Li, H., & Tu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114949 · Cited by 25
“IL-17a plays an important role in chronic inflammation, auto-immune diseases, and immune rejection [38–40].”
BackgroundSun, J., XU, P., Du, X., ZHANG, Q., & Zhu, Y. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3001 · Cited by 25
Kawabe, T., Suzuki, N., Yamaki, S., Sun, S., Asao, A., Okuyama, Y., So, T., Iwakura, Y., & Ishii, N. (2016) · European Journal of Immunology · doi:10.1002/eji.201545907 · Cited by 28
Interplay between myeloid-derived suppressor cells (MDSCs) and Th17 cells: foe or friend?
Wen, L., Gong, P., Liang, C., Shou, D., Liu, B., Chen, Y., Bao, C., Chen, L., Liu, X., Liang, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8204 · Cited by 25
“They also participate in regulating immune responses in other pathological conditions, such as autoimmune diseases, chronic inflammation, tumors and transplant rejection [20, 21].”
BackgroundDevelopmental cell death programs license cytotoxic cells to eliminate histocompatible partners
Corey, D. M., Rosental, B., Kowarsky, M., Sinha, R., Ishizuka, K. J., Palmeri, K. J., Quake, S. R., Voskoboynik, A., & Weissman, I. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606276113 · Cited by 25
“Its dysregulation results in excessive inflammation, leading to tissue damage, chronic inflammation (22), autoimmunity (23), and chronic graft-versus-host disease in higher vertebrates (24).”
BackgroundMoore, C. A., Iasella, C. J., Venkataramanan, R., Lakkis, F. G., Smith, R. B., McDyer, J. F., Zeevi, A., & Ensor, C. R. (2016) · Human Immunology · doi:10.1016/j.humimm.2016.12.005 · Cited by 25
Identification and biological evaluation of thiazole-based inverse agonists of RORγt
Gege, C., Cummings, M. D., Albers, M., Kinzel, O. D., Kleymann, G., Schlüter, T., Steeneck, C., Nelen, M. I., Milligan, C., Spurlino, J. C., et al. (2018) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2018.03.093 · Cited by 25
Zhang, X., Yuan, Y., Pan, Z., Ma, Y., Wu, M., Yang, J., Han, R., Chen, M., Hu, X., Liu, R., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.06.026 · Cited by 28
Spalinger, M. R., Schwarzfischer, M., Hering, L., Shawki, A., Sayoc, A., Santos, A. N., Gottier, C., Lang, S., Bäbler, K., Geirnaert, A., et al. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0201-1 · Cited by 27
Kim, K., Hong, G.-L., Jung, D.-Y., Karunasagara, S., Jeong, W., & Jung, J. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00285-4 · Cited by 29
“IL-17 proteins play a positive role in regulating chronic diseases such as psoriasis vulgaris, multiple sclerosis, and rheumatoid arthritis by enhancing the induction of cytokines and extracellular proteins (Miossec and Kolls 2012; Beringer et al.”
BackgroundWang, X., Zhang, F., & Liao, L. (2021) · Frontiers in Surgery · doi:10.3389/fsurg.2021.664404 · Cited by 29
“Previous studies have also demonstrated that it was necessary to synergistically inhibit multiple pro-fibrotic cascade reactions (61, 62).”
BackgroundHuman monocyte-derived dendritic cells turn into foamy dendritic cells with IL-17A
Salvatore, G., Bernoud‐Hubac, N., Bissay, N., Debard, C., Daira, P., Meugnier, E., Proamer, F., Hanau, D., Vidal, H., Aricò, M., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054874 · Cited by 28
Park, J. S., Oh, Y., Park, O., Foss, C. A., Lim, S. M., Jo, D., Na, D. H., Pomper, M. G., Lee, K. C., & Lee, S. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.004 · Cited by 24
Kajikawa, T., Wang, B., Li, X., Wang, H., Chavakis, T., Moutsopoulos, N. M., & Hajishengallis, G. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.5hi0420-648r · Cited by 26
Does hereditary angioedema make COVID-19 worse?
Xu, Y., Liu, S., Zhang, Y., & Zhi, Y. (2020) · World Allergy Organization Journal · doi:10.1016/j.waojou.2020.100454 · Cited by 24
“60 A pathologic study of COVID-19 found an increase in Th17 cells, 61 which are differentiated from Th0 cells by the stimulation of IL-6, TGF-b , IL-21 and IL-23.”
Immunopathogenesis of viral infections in neurological autoimmune disease
Habibi, M. A., Shamohammadi, F. N., Rajaei, T., Namdari, H., Pashaei, M. R., Farajifard, H., & Ahmadpour, S. (2023) · BMC Neurology · doi:10.1186/s12883-023-03239-x · Cited by 27
“In Covid-19 patients, Th17 levels increase, which regulates inflammatory conditions by increasing IL-6 and IL-23, indicating the pivotal role of this cell in the production of Cytokines Storm, which provides the requirements for MS [150].”
BackgroundInhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis
Hu, Z., Hua, X., Mo, X., Chang, Y., Chen, X., Xu, Z., Tao, M., Hu, G., & Song, J. (2023) · iScience · doi:10.1016/j.isci.2023.107162 · Cited by 24
“Th17 cells have been seen as candidate therapeutics for the treatment of autoimmune diseases.(55) In the future, inhibitors that target Th17 cells could be investigated to determine whether they are helpful for patients with GCM.”
BackgroundCytokine crowdsourcing: multicellular production of TH17-associated cytokines
Busman‐Sahay, K., Walrath, T., Huber, S., & O’Connor, W. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3ru0814-386r · Cited by 26
“diseases, such as arthritis [3, 4] and psoriasis [5, 6], is now well established.”
Combined Blockade of IL-17A and IL-17F May Prevent the Development of Experimental Colitis
McLean, L. P., Cross, R. K., & Shea‐Donohue, T. (2013) · Immunotherapy · doi:10.2217/imt.13.87 · Cited by 24
Zhang, M., Fei, X., Zhang, G.-Q., Zhang, P., Li, F., Bao, W., Zhang, Y., & Zhou, X. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.041 · Cited by 25
A fully humanized IgG-like bispecific antibody for effective dual targeting of CXCR3 and CCR6
Robert, R., Juglair, L., Lim, E. X., Ang, C., Wang, C. J. H., Ebert, G., Dolezal, O., & Mackay, C. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184278 · Cited by 25
Diagnostic and prognostic value of serum IL-23 in colorectal cancer
El‐Essawi, D. F., Alkady, M. M., & Ibrahim, I. M. (2019) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2019.05.002 · Cited by 25
New insights into the taxonomy of autoimmune diseases based on polyautoimmunity
Rojas, M., Ramírez-Santana, C., Acosta‐Ampudia, Y., Monsalve, D. M., Rodríguez‐Jiménez, M., Zapata, E., Naranjo-Pulido, A., Suárez-Avellaneda, A., Ríos-Serna, L. J., Prieto, C., et al. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102780 · Cited by 24
Emerging roles and therapeutic implications of HDAC2 and IL-17A in steroid-resistant asthma
Ouyang, L., Su, G., Quan, J., Xiong, Z., & Lai, T. (2023) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2023.04.003 · Cited by 25
Li, L., Chen, L., Lin, F., Mu, J., Wang, D., Zhang, W., Mi, L., Yuling, Q., & Zhou, Y.-S. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s302975 · Cited by 26
Iwata, H., Haga, N., & Ujiie, H. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.16003 · Cited by 23
Shao, B., Zhou, D., Wang, J., Yang, D., & Gao, J. (2023) · Aging · doi:10.18632/aging.204895 · Cited by 24
Zhang, W., Li, M., Li, X., Wang, X., Liu, Y., & Yang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1328439 · Cited by 23
“Interleukin-17 (IL-17) is a pro-in fl ammatory cytokine derived mainly from TCD4+T cells and helper T subtype 17 cells (37).”
BackgroundClass IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
Cheung, K. L., Zhao, L., Sharma, R., Ghosh, A., Appiah, M. G., Sun, Y., Jaganathan, A., Hu, Y., Lejeune, A., Xu, F., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2312111121 · Cited by 26
Wu, C., GOODALL, J. C., Busch, R., & Gaston, H. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12434 · Cited by 23
Zhou, Q., Hu, Y. N., Howard, O. M. Z., Oppenheim, J. J., & Chen, X. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.008 · Cited by 24
“This was achieved by 1) blocking the differentiation and amplification of Th17 cells; or 2) inhibiting or neutralizing of Th17 cytokines and their receptors, or 3) suppressing the transcription factors specific for Th17 cells [4, 5].”
BackgroundRisk of psoriasis in patients with childhood asthma: a Danish nationwide cohort study
Egeberg, A., Khalid, U., Gislason, G., Mallbris, L., Skov, L., & Hansen, P. R. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13781 · Cited by 23
Azevedo, M. D. C. S., Rosa, P. S., Soares, C. T., Fachin, L. R. V., Baptista, I. M. F. D., Woods, W. J., Garlet, G. P., Trombone, A. P. F., & Belone, A. D. F. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145814 · Cited by 23
“While macrophages and fibroblasts may be responsible for IL-17 expression in the lesions [49,50,51], the putative inhibitory effect that Tregs have on Th17 cells may be critical in preventing the development of comprehensive Th17 responses in the lesions.”
BackgroundLereclus, E., Tout, M., Girault, A., Baroukh, N., Caulet, M., Borg, C., Bouché, O., Ternant, D., Paintaud, G., Lecomte, T., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3210-z · Cited by 23
“A major source of IL-17 is a lineage of T cells known as CD4 T helper 17 cells (Th17 cells) which differ from the Th1 and Th2 subsets [20].”
BackgroundFan, H., Lu, B., Yang, D., Zhang, D., Shi, T., & Lu, G. (2019) · Japanese Journal of Infectious Diseases · doi:10.7883/yoken.jjid.2019.113 · Cited by 30
“Total days with cough (d), median(range) 15 (0-30) 27(2-27) 0.”
BackgroundWang, R., & Maksymowych, W. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.715510 · Cited by 27
Vasculitogenic T Cells in Large Vessel Vasculitis
Watanabe, R., & Hashimoto, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923582 · Cited by 24
“Th17 cells produce IL-17, IL-21, and IL-22, and the IL-17 family includes six isoforms (IL-17A to IL-17F) (52).”
BackgroundConcurrent treatment of chronic psoriasis and asthma with ustekinumab
Amarnani, A., Rosenthal, K. S., Mercado, J. M., & Brodell, R. T. (2013) · Journal of Dermatological Treatment · doi:10.3109/09546634.2013.782095 · Cited by 23
“The IL-12p40 subunit is present in both cytokines with IL-12 made up of p40 and p35 subunits, and IL-23 of p40 and p19 subunits.”
BackgroundInfluentialEvaluation of the anti-inflammatory and analgesic effects of green tea (Camellia sinensis) in mice
Mota, M. A. D. L., Landim, J. S. P., Targino, T. S. S., da Silva, S. F. R., da Silva, S. L., & Pereira, M. R. (2015) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-865020150040000002 · Cited by 23
People are an organic unity: Gut-lung axis and pneumonia
Guo, J., Wang, L., Han, N., Yuan, C., Yin, Y., Wang, T., Sun, J., Jin, P., Liu, Y., & Jia, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27822 · Cited by 26
“Th17 has also been reported to be a key participant in psoriasis, Rheumatoid arthritis, Crohn ’ s disease, Ulcerative colitis, multiple sclerosis, and Ankylosing spondylitis [33,42,43].”
BackgroundImmunometabolism in the Aging Heart
Mapuskar, K. A., London, B., Zacharias, Z. R., Houtman, J. C. D., & Allen, B. G. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.039216 · Cited by 26
“180,181 Among these, T-helper 17 has emerged as a marker in the context of cardiovascular diseases.”
Khatri, A., Goss, S. L., Jiang, P. X., Mansikka, H. T., & Othman, M. I. A. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0580-y · Cited by 22
Role of interleukin-17 in human papillomavirus infection and associated malignancies
Sahu, U., & Khare, P. S. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105294 · Cited by 25
Li, W., Ding, Z., Chen, Y., Wang, Y., Peng, M., Li, C., Zhang, H., Zhong, R., Xia, T., Zhong, L., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.854544 · Cited by 25
“IL-17 is a major effector of Th17 cells, which are cytokines that cause inflammation (Miossec and Kolls, 2012).”
BackgroundIL-17A-targeting fenofibrate attenuates inflammation in psoriasis by inducing autophagy
Park, A., & Heo, T. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121755 · Cited by 26
Hu, X., Ren, J., Xue, Q., Luan, R., Ding, D., Tan, J., Su, X., & Yang, J. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5570 · Cited by 24
A multiscale inflammatory map: linking individual stress to societal dysfunction
Vodovotz, Y., Arciero, J. C., Verschure, P. F. M. J., & Katz, D. L. (2024) · Frontiers in Science · doi:10.3389/fsci.2023.1239462 · Cited by 25
Kessler, S., Burke, B. E., Andrieux, G., Schinköthe, J., Hamberger, L., Kacza, J., Zhan, S., Reasoner, C., Dutt, T. S., Osman, M. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48934-6 · Cited by 25
Gürsoy, U. K., Çiftlikli, S. Y., Könönen, E., Gürsoy, M., & Doğan, B. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12228 · Cited by 29
“IL-17 is involved in the differentiation of neutrophils (granulopoiesis) and can activate nuclear factor-κB or mitogen-activated protein kinases to upregulate proinflammatory cytokines, antimicrobial peptides, and matrix metalloproteinases (MMPs).(23) Moreover, Turner-Brannen et al.”
BackgroundPharmacological approaches to regulate neutrophil activity
Tintinger, G. R., Anderson, R., & Feldman, C. H. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0366-8 · Cited by 23
Potential role of myeloid cell/eosinophil-derived IL-17 in LPS-induced endotoxin shock
Shimura, E., Shibui, A., Narushima, S., Nambu, A., Yamaguchi, S., Akitsu, A., Leonard, W. J., Iwakura, Y., Matsumoto, K., Suto, H., et al. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.004 · Cited by 23
“, IL-17RA, IL-17RB, IL-17RC, IL-17RD and IL-17RE, have been identified as members of the IL-17 cytokine and IL-17R receptor families, respectively [1,2].”
BackgroundZare, F., Dehghan-Manshadi, M., & Mirshafiey, A. (2016) · Reumatismo · doi:10.4081/reumatismo.2015.851 · Cited by 22
A Review of the Use of Secukinumab for Psoriatic Arthritis
Patel, N., Vera, N., Shealy, E. R., Wetzel, M. E., & Feldman, S. R. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0076-0 · Cited by 22
“In this way, activation of the downstream inflammatory cascade is halted, while other immune functions are not disturbed [5, 8].”
BackgroundTh17/Treg immunoregulation and implications in treatment of sulfur mustard gas-induced lung diseases
Iman, M., Rezaei, R., Jamalkandi, S. A., Shariati, P., Kheradmand, F., & Salimian, J. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1389646 · Cited by 25
“ing SCH-900117 and RG4934 (Perakizumab) are in phase I of clinical trials for inflammatory disease [34,137].”
BackgroundInfluentialIntestinal Organoids as a Novel Complementary Model to Dissect Inflammatory Bowel Disease
Schulte, L.-A., Hohwieler, M., Müller, M., & Klaus, J. (2019) · Stem Cells International · doi:10.1155/2019/8010645 · Cited by 23
“In a bedside setting, despite strong experimental evidence, disruption of IL-17A signaling by anti-IL-17A antibody secukinumab led to acute exacerbations of CD [104, 105].”
Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms
Martínez‐Hervás, S., & Navarro, H. G. (2019) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2019.03.007 · Cited by 23
Oh, S., Shim, M., Son, M., Jang, J. T., Son, K. H., & Byun, K. (2021) · Antioxidants · doi:10.3390/antiox10020298 · Cited by 24
“NF-B activates C/EBPβ and C/EBPδ, leading to an increase in the transcription of IL-6 [69].”
BackgroundKothari, H., Williams, C. M., McSkimming, C. C., Drago, F., Marshall, M. A., Garmey, J. C., Vigneshwar, M., Zunder, E. R., & McNamara, C. A. (2021) · Science Signaling · doi:10.1126/scisignal.abc5763 · Cited by 24
Evaluation of Th17 and Treg cytokines in patients with unexplained recurrent pregnancy loss
Farshchi, M., Abdollahi, E., Saghafi, N., Hosseini, A., Fallahi, S., Rostami, S., Rostami, P., Rafatpanah, H., & Habibagahi, M. (2022) · Journal of Clinical and Translational Research · doi:10.18053/jctres.08.202203.001 · Cited by 22
“In humans, IL-17 has been involved in the development and progression of inflammatory and autoimmune diseases, as well as transplant rejection [36,40-43].”
BackgroundGe, C., & He, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.556984 · Cited by 24
“Hyper-activation of these pathways is involved in the SARS-CoV-2 infection, leading to the induction of a variety of pro-inflammatory cytokines, including IL-6, TNFa, and chemokines (Miossec and Kolls, 2012; Murakami et al., 2019; Xu et al., 2020).”
BackgroundZhao, Z., Zhang, Y., Gao, D., Zhang, Y., Han, W., Xu, X., Song, Q., Zhao, C., & Yang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.818070 · Cited by 24
“IL17 was suggested to increase IL6 transcription in turn (69), which might be another feedback mechanism that GSK-J4 regulates IL6 transcription.”
BackgroundRole of CD4+ T cell-derived cytokines in the pathogenesis of uveitis
Meng, T., Nie, L., & Wang, Y. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01565-7 · Cited by 23
“Th17 cells are predominantly involved in the inflammatory process, secreting IL-17, which recruits neutrophils and promotes tissue inflammation (19).”
Way, E. E., Trevejo-Nuñez, G., Kane, L., Steiner, B. H., Puri, K. D., Kolls, J. K., & Chen, K. (2016) · Scientific Reports · doi:10.1038/srep30384 · Cited by 21
Self-citationFollistatin‐like protein 1 modulates IL‐17 signaling via IL‐17RC regulation in stromal cells
Campfield, B. T., Eddens, T. J., Henkel, M., Majewski, M., Horne, W. T., Chaly, Y., Gaffen, S. L., Hirsch, R., & Kolls, J. K. (2017) · Immunology and Cell Biology · doi:10.1038/icb.2017.26 · Cited by 27
Self-citationKono, M., Oda, T., Tawada, M., Imada, T., Banno, Y., Taya, N., Kawamoto, T., Tokuhara, H., Tomata, Y., Ishii, N., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.008 · Cited by 23
Mangas, K. M., Buultjens, A. H., Porter, J. L., Baines, S. L., Marion, E., Marsollier, L., Tobias, N. J., Pidot, S. J., Quinn, K. M., Price, D. J., et al. (2019) · Infection and Immunity · doi:10.1128/iai.00753-19 · Cited by 22
“tion, autoimmunity, and vascular activation (91).”
Zhou, X., Johnson, J. S., Spakowicz, D. J., Zhou, W., Zhou, Y., Sodergren, E. J., Snyder, M. P., & Weinstock, G. M. (2020) · Diabetes · doi:10.2337/db19-0592 · Cited by 23
“Human isolates from three of these Clostridium clusters (XIVa, XIVb, IV) were previously found to induce Th17 cells (a major producer of IL-17 and IL-22 [54,55] in mice [56]).”
BackgroundInfluentialSecukinumab in axial spondyloarthritis: a narrative review of clinical evidence
Braun, J., Kiltz, U., Buehring, B., & Baraliakos, X. (2021) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x211041854 · Cited by 21
Loughran, S. T., Power, P., Maguire, P. T., McQuaid, S., Buchanan, P., Jónsdóttir, I., Newman, R. W., Harvey, R., & JOHNSON, P. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203521 · Cited by 22
IL-17 antibodies gain momentum
Tse, M. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4152 · Cited by 21
Advances in hydrogels for capturing and neutralizing inflammatory cytokines
Qin, H., Li, Z., Li, S., Huang, J., Ren, J., & Wu, X. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251342175 · Cited by 22
VIu, M., Orlova, Y. A., Павликова, Е. П., Akopyan, Z. A., Мацкеплишвили, С. Т., Геннадьевна, П. А., Seredenina, E. M., Potapenko, A. V., Малахов, П. С., Samokhodskaya, L. M., et al. (2020) · Kardiologiia · doi:10.18087/cardio.2020.9.n1338 · Cited by 22
Jiang, J., Kao, T.-C., Hu, S., Li, Y., Feng, W., Guo, X., Zeng, J., & Ma, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154777 · Cited by 20
Li, J., Yang, P., Wu, Q., Li, H., Ding, Y., Hsu, H., Spalding, D. M., & Mountz, J. D. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38057 · Cited by 22
Discovery of biaryls as RORγ inverse agonists by using structure-based design
Enyedy, I. J., Powell, N. A., Caravella, J. A., van Vloten, K., Chao, J., Banerjee, D., Marcotte, D. J., Silvian, L. F., McKenzie, A., Hong, V. S., et al. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.03.109 · Cited by 20
MicroRNAs as T Lymphocyte Regulators in Multiple Sclerosis
Wang, L., & Liang, Y. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.865529 · Cited by 24
IL-23R is Epigenetically Regulated and Modulated by Chemotherapy in Non-Small Cell Lung Cancer
Baird, A., Dockry, É., Daly, A. K., Stack, E., Doherty, D. G., O'Byrne, K. J., & Gray, S. G. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00162 · Cited by 20
Valiathan, R., & Asthana, D. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.01.002 · Cited by 20
Camelo, S., Lavelette, S., Guillonneau, X., Raoul, W., & Sennlaub, F. (2016) · Ophthalmologica · doi:10.1159/000446587 · Cited by 21
Biochanin A enhances RORγ activity through STAT3-mediated recruitment of NCOA1
Takahashi, M., Muromoto, R., Kojima, H., Takeuchi, S., Kitai, Y., Kashiwakura, J., & Matsuda, T. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.181 · Cited by 22
Quantification of Th1 and Th17 Cells with Intracellular Staining Following PMA/Ionomycin Stimulation
Karlsson, F. J., & Hassan‐Zahraee, M. (2015) · Current Protocols in Cytometry · doi:10.1002/0471142956.cy0635s71 · Cited by 19
“Quantification of Th1 and Th17 cells can provide important information in research of these diseases and other Th1 and/or Th17 mediated immune disorders (Petermann and Korn, 2011; Miossec and Kolls, 2012; Monteleone et al., 2012).”
BackgroundSu, Q. Y., Zheng, J., Yang, J.-Y., Zhang, T.-Y., Shan, S., Rong, Z., Di, J., Zhang, S., Wang, C., & Gao, H.-Y. (2022) · Advances in Therapy · doi:10.1007/s12325-022-02240-z · Cited by 26
“IL-17 is a major effector molecule produced by Th17 cells [7, 8] that stimulates chemokine production and attracts macrophages and neutrophils.”
BackgroundXie, D., Quan, J., Yu, X., Liang, Z., Chen, Y., Wu, L., Lin, L., & Fan, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2023.155273 · Cited by 21
The gut-liver axis in hepatobiliary diseases
Ichikawa, M., Okada, H., Nakamoto, N., Taniki, N., Chu, P., & Kanai∥, T. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-023-00315-0 · Cited by 19
“PRRs, especially TLRs, are innate immune sensors that respond to microbial signals by recruiting specific adaptor elements, including myeloid differentiation primary response 88 (MyD88), and activating transcription factors, such as nuclear factor kappa B (NF-κB) [41].”
BackgroundZeng, L., Yu, G., Yang, K., He, Q., Hao, W., Wang, X., Long, Z., Chen, H., Tang, X., & Sun, L. (2024) · Scientific Reports · doi:10.1038/s41598-023-48248-5 · Cited by 19
“IL-17A is a pro-inflammatory cytokine and a regulator of inflammatory response, which directly or indirectly promotes and aggravates joint inflammation through a series of reactions 100 .”
BackgroundPan, Z., Yu, H., & Liao, J.-L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163192 · Cited by 19
Metadata
- Authors
- Miossec, P., & Kolls, J. K.
- Affiliations
- Lyon 1 Université (FR)
- University of Pittsburgh (US)
- Corresponding author
- Miossec, Pierre
- Kolls, Jay K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2012-10
- Volume
- 11
- Issue
- 10
- Pages
- 763-776
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2022917731
- Cited by
- 1,414
- References
- 169
- Citations by year
- 2026: 74 · 2025: 104 · 2024: 137 · 2023: 101 · 2022: 121 · 2021: 129 · 2020: 97 · 2019: 91 · 2018: 67 · 2017: 114 · 2016: 100 · 2015: 109 · 2014: 97 · 2013: 72 · 2012: 1
- FWCI
- 8.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Institut Universitaire de France
- Institut Mérieux
- National Heart, Lung, and Blood Institute (R37HL079142)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17, Th17 cells, IL-17 inhibitors, IL-23, IL-17 receptor A, psoriasis, rheumatoid arthritis, ankylosing spondylitis, chronic inflammation, autoimmunity, biologic therapy, IL-17A
- MeSH terms
- Animals, Chronic Disease, Humans, Inflammation, Drug Delivery Systems, Interleukin-17, Receptors, Interleukin-17, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.